Virtu Financial LLC Gamida Cell Ltd. Transaction History

Virtu Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 20, 2024	BUY	$0.04 - $0.46 $3,709 - $42,662	92,745 New	92,745 $3,000
Q1 2023 May 01, 2023	BUY	$0.68 - $1.71 $22,130 - $55,651	32,545 New	32,545 $26,000
Q3 2022 Nov 07, 2022	BUY	$1.53 - $3.39 $17,850 - $39,551	11,667 Added 57.6%	31,922 $51,000
Q2 2022 Aug 09, 2022	BUY	$1.73 - $4.29 $35,041 - $86,893	20,255 New	20,255 $36,000
Q2 2021 Sep 17, 2021	SELL	$5.85 - $8.33 $114,507 - $163,051	-19,574 Closed	0 $0
Q1 2021 May 19, 2021	SELL	$7.8 - $12.43 $111,641 - $177,910	-14,313 Reduced 42.24%	19,574 $158,000
Q4 2020 Feb 24, 2021	BUY	$4.07 - $11.0 $57,041 - $154,165	14,015 Added 70.53%	33,887 $284,000
Q3 2020 Dec 11, 2020	BUY	$3.93 - $4.59 $78,096 - $91,212	19,872 New	19,872 $82,000

2.2K

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.